|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,081.00 GBX | +1.12% |
|
-1.14% | +4.37% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last hours
Enjoy this offer
* See conditions on site
| Capitalization | 5.93B 5.42B 5.2B 4.56B 8.48B 513B 9.32B 59.59B 22.67B 218B 22.24B 21.78B 887B | P/E ratio 2024 |
15.5x | P/E ratio 2025 * | 12.5x |
|---|---|---|---|---|---|
| Enterprise value | 6.95B 6.36B 6.1B 5.35B 9.95B 602B 10.93B 69.88B 26.59B 255B 26.08B 25.54B 1,040B | EV / Sales 2024 |
2.13x | EV / Sales 2025 * | 2.1x |
| Free-Float |
65.88% | Yield 2024 |
3.21% | Yield 2025 * | 3.08% |
More valuation ratios
* Estimated data
More news
Last Transcript: Hikma Pharmaceuticals PLC
More recommendations
More press releases
More news
| 1 day | +0.92% | ||
| 1 week | -1.43% | ||
| Current month | -3.98% | ||
| 1 month | -10.53% | ||
| 3 months | +7.57% | ||
| 6 months | +8.36% | ||
| Current year | +4.06% |
1 week
1,994
2,104
1 month
1,994
2,330
Current year
1,973
2,360
1 year
1,750
2,360
3 years
1,174.5
2,360
5 years
1,174.5
2,768
10 years
814.2
2,768
| Manager | Title | Age | Since |
|---|---|---|---|
Riad Mishlawi
CEO | Chief Executive Officer | 61 | 31/08/2023 |
Khalid Nabilsi
DFI | Director of Finance/CFO | 53 | 31/12/2000 |
Hill Julie
CMP | Compliance Officer | - | 31/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 67 | 13/10/2005 | |
Said Darwazah
CHM | Chairman | 67 | 14/05/2014 |
Riad Mishlawi
BRD | Director/Board Member | 61 | 31/12/1989 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.44% | 1,049 M€ | +10.52% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.92% | -1.43% | +10.14% | +0.68% | 5.93B | ||
| -0.27% | -0.19% | +7.85% | +185.95% | 739B | ||
| +0.87% | -0.97% | +4.78% | -6.06% | 396B | ||
| -0.29% | +0.12% | +19.81% | +34.33% | 378B | ||
| -0.27% | +2.43% | -40.56% | +46.55% | 358B | ||
| -0.79% | +3.31% | +33.41% | -16.43% | 282B | ||
| -0.07% | -0.01% | -22.00% | +19.73% | 239B | ||
| +0.36% | +3.22% | +15.16% | +24.27% | 239B | ||
| -0.10% | +2.65% | +14.86% | +21.61% | 222B | ||
| +0.47% | -0.08% | +17.63% | +34.88% | 171B | ||
| Average | +0.03% | +1.06% | +6.11% | +34.55% | 302.88B | |
| Weighted average by Cap. | -0.14% | +1.12% | +4.89% | +59.83% |
| 2024 | 2025 * | |
|---|---|---|
| Net sales | 3.09B 2.82B 2.71B 2.37B 4.41B 267B 4.85B 31.01B 11.8B 113B 11.57B 11.33B 462B | 3.27B 2.99B 2.86B 2.51B 4.67B 282B 5.13B 32.81B 12.49B 120B 12.25B 11.99B 488B |
| Net income | 436M 399M 382M 335M 623M 37.7B 685M 4.38B 1.67B 15.98B 1.63B 1.6B 65.19B | 475M 434M 416M 365M 679M 41.05B 746M 4.77B 1.81B 17.41B 1.78B 1.74B 70.99B |
| Net Debt | 1.02B 937M 898M 788M 1.46B 88.6B 1.61B 10.29B 3.92B 37.57B 3.84B 3.76B 153B | 921M 843M 808M 709M 1.32B 79.7B 1.45B 9.26B 3.52B 33.79B 3.46B 3.38B 138B |
More financial data
* Estimated data
Employees
9,500
Sector
Pharmaceuticals
Calendar
03-19
- Final dividend
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/03/25 | 2,080.00 p | +1.07% | 42,730 |
| 18/03/25 | 2,058.00 p | +1.38% | 417,732 |
| 17/03/25 | 2,030.00 p | +0.89% | 419,848 |
| 14/03/25 | 2,012.00 p | -0.20% | 579,536 |
| 13/03/25 | 2,016.00 p | -2.70% | 1,812,723 |
Delayed Quote London S.E., March 19, 2025 at 09:17 am
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
26.74USD
Average target price
31.44USD
Spread / Average Target
+17.57%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HIK Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition